---

---

symbols : AMGN   

save search

---

Rare Diseases Global Market Report 2023: Revenue Set to Surpass $205 Billion in 2023
Published: 2023-07-03 (Crawled : 17:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -7.76% | O: -1.21% H: 0.03% C: -0.92%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -12.43% | O: -0.71% H: 0.03% C: -0.6%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -24.47% | O: -0.02% H: 1.51% C: 0.77%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 22.59% | O: -0.54% H: 1.07% C: 0.75%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -14.88% | O: 1.24% H: 0.0% C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -31.49% | O: -0.7% H: 0.98% C: 0.91%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 19.33% | O: -0.36% H: 1.97% C: 1.72%
rare report global set market

---

United States Biosimilar Market Report 2023: Sector is Expected to Reach $50.68 Billion in 2027 at a CAGR of 40.17%
Published: 2023-06-30 (Crawled : 19:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
biosimilar report expected reach market

---

Nasdaq Welcomed 60 IPOs in the First Half of 2023
Published: 2023-06-28 (Crawled : 11:00) - globenewswire.com
WDFC P | $229.8 -0.03% -0.03% 170K |

Process Industries

| 24.5% | O: 0.02% H: 0.0% C: -0.55%
NDAQ | $60.35 0.47% 0.46% 3.1M |

Finance

| 20.45% | O: 0.06% H: 0.37% C: -0.54%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 19.01% | O: -0.17% H: 0.05% C: -0.42%
AGNC | $9.15 0.99% 0.98% 10M |

Finance

| -12.93% | O: 0.1% H: 0.34% C: 0.19%

---

FDA GRANTS FULL APPROVAL FOR BLINCYTO® (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Published: 2023-06-21 (Crawled : 14:20) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K |

Health Technology

| -30.03% | O: -0.8% H: 0.36% C: -2.33%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 15.9% | O: -0.18% H: 0.8% C: -0.5%
blincyto fda approval treat grants leukemia

---

Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published: 2023-06-15 (Crawled : 10:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -35.42% | O: 0.13% H: 1.07% C: 0.86%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.62% | O: 1.04% H: 0.78% C: 0.67%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 67.69% | O: 0.06% H: 1.91% C: 1.32%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 19.19% | O: 0.33% H: 2.62% C: 2.43%
market

---

Longeveron Welcomes Three New Prominent Board Members
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
LGVN 1 d | $1.93 -3.98% -4.15% 460K |

| -45.08% | O: 2.46% H: 2.93% C: 0.8%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 68.59% | O: -0.37% H: 0.84% C: 0.46%
PCSA | $1.58 1.28% 1.27% 19K |

Producer Manufacturing

| -88.63% | O: 4.95% H: 0.0% C: -9.91%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 21.89% | O: 0.03% H: 2.26% C: 2.1%

---

Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -42.42% | O: -0.68% H: 3.23% C: 1.55%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -7.78% | O: -0.16% H: 0.11% C: -0.76%
ORTX | $16.7 0.0% 370K |

Health Technology

| 241.48% | O: 0.62% H: 4.57% C: 2.04%
GBIO | $2.81 1.08% 1.07% 250K |

Health Technology

| -38.43% | O: 0.0% H: 11.57% C: 6.4%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -36.82% | O: 3.52% H: 0.0% C: -1.99%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 21.11% | O: 0.22% H: 0.0% C: -0.86%
ADAP | $0.97 7.97% 7.38% 1.5M |

Health Technology

| 4.31% | O: -0.75% H: 7.14% C: 6.12%
ABEO | $7.6 0.93% 0.92% 390K |

Health Technology

| 77.18% | O: 0.0% H: 4.4% C: 3.29%
drug set therapy growth market

---

AMGEN TO PRESENT AT THE GOLDMAN SACHS 44TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Published: 2023-06-09 (Crawled : 20:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
conference global

---

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| -7.89% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 14.25% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -18.27% | O: -0.62% H: 0.88% C: 0.81%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -5.5% | O: 1.26% H: 1.08% C: 0.91%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 15.25% | O: 0.41% H: 0.68% C: 0.64%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 72.05% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -25.87% | O: 0.28% H: 0.42% C: -0.05%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -21.24% | O: 0.39% H: 0.15% C: -0.79%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -6.88% | O: -0.23% H: 1.83% C: 1.52%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 19.74% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

---

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-06-06 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| -6.81% | O: 1.18% H: 0.37% C: -0.99%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 14.48% | O: 1.88% H: 0.0% C: -1.15%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| 2.78% | O: 0.66% H: 0.23% C: -1.1%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.33% | O: 0.91% H: 0.1% C: -0.61%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 20.68% | O: 0.45% H: 0.05% C: -1.48%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -10.76% | O: 0.94% H: 0.27% C: 0.02%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -6.74% | O: 0.79% H: 0.27% C: -0.52%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 19.4% | O: 0.54% H: 0.04% C: -0.83%
growing growth market

---

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023
Published: 2023-06-04 (Crawled : 12:20) - prnewswire.com
BEIGF | $14.29 -9.87% 2.1K |

n/a

| Email alert Add to watchlist
BGNE | $129.51 -1.86% -1.89% 300K |

Health Technology

| Email alert Add to watchlist
CCXI | $51.99 -0.04% |

Health Technology

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
lumakras asco

---

Autoinjectors Market worth $1.7 billion | MarketsandMarkets
Published: 2023-06-02 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 15.61% | O: 0.99% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 21.13% | O: 0.76% H: 1.08% C: 0.86%
WST | $372.04 -1.4% 0.0% 440K |

Health Technology

| 10.49% | O: 0.34% H: 0.36% C: 0.3%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -4.15% | O: 1.03% H: 0.84% C: 0.82%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 72.0% | O: 0.79% H: 1.08% C: 0.54%
BDX | $234.12 0.42% 0.0% 1.3M |

Health Technology

| -6.89% | O: 0.56% H: 1.61% C: 0.92%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 23.77% | O: 0.2% H: 2.44% C: 2.36%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 23.65% | O: -0.24% H: 2.34% C: 2.02%
market

---

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023
Published: 2023-05-30 (Crawled : 22:00) - prnewswire.com
BGNE | $129.51 -1.86% -1.89% 300K |

Health Technology

| -41.28% | O: -1.13% H: 0.19% C: -2.1%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 21.24% | O: 0.48% H: 1.03% C: 0.49%
otezla research

---

AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT
Published: 2023-05-26 (Crawled : 20:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
innovation

---

Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA
Published: 2023-05-25 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 14.08% | O: -0.49% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.95% | O: -1.37% H: 0.0% C: -0.89%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 19.71% | O: -0.55% H: 0.0% C: -1.2%
biosimilar authorization ema

---

Atherosclerosis Drugs Market to Reach $27.7 Billion, Globally, by 2032 at 3.0% CAGR: Allied Market Research
Published: 2023-05-23 (Crawled : 09:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 10.85% | O: -1.22% H: 0.0% C: -0.62%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -7.6% | O: 0.74% H: 0.0% C: -1.22%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -7.6% | O: 0.15% H: 0.74% C: -0.18%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -0.68% | O: -2.27% H: 4.24% C: -2.21%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -16.26% | O: -0.01% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 18.28% | O: 0.1% H: 1.16% C: 0.1%
reach research market

---

Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors - Technavio
Published: 2023-05-19 (Crawled : 00:20) - prnewswire.com
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| Email alert Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
pharma abbvie market

---

Global Quantum Technology Market Analysis Report 2023: A $53.2 Billion Market by 2028 - North America will Lead, China will Lead APAC Whilst Germany will Lead the European Market
Published: 2023-05-19 (Crawled : 10:00) - prnewswire.com
NOKBF | News | $3.38 -2.55% 1.5K |

Electronic Technology

| -19.22% | O: -0.54% H: 1.81% C: 1.61%
QUBT | $0.7108 -7.69% -8.33% 990K |

Information

| -40.74% | O: 1.48% H: 0.0% C: -5.11%
NOK | News | $3.52 2.03% 0.0% 17M |

Electronic Technology

| -16.08% | O: 1.0% H: 1.23% C: 0.0%
LMT | $463.87 1.71% 0.0% 1.4M |

Electronic Technology

| 0.07% | O: 0.28% H: 0.27% C: -0.56%
HON | News M | $194.27 1.67% 1.64% 3.6M |

Producer Manufacturing

| -3.87% | O: 0.63% H: 0.38% C: -1.08%
BABA | $69.07 0.28% -0.07% 13M |

Retail Trade

| -18.84% | O: -2.24% H: 1.61% C: 0.16%
MSFT | News F | $399.09 -1.28% -1.3% 29M |

Technology Services

| 29.01% | O: -0.56% H: 0.63% C: 0.51%
INTC | $34.2 -2.4% -2.46% 58M |

Electronic Technology

| 19.31% | O: -0.27% H: 2.16% C: 1.11%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -36.11% | O: 0.51% H: 1.14% C: 0.48%
AAPL | News S | $164.96 -1.24% -1.32% 67M |

Electronic Technology

| -3.99% | O: 0.77% H: 0.0% C: -0.7%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 18.15% | O: 0.09% H: 0.64% C: -0.45%
america quantum report germany global technology china market

---

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
Published: 2023-05-19 (Crawled : 09:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M |

n/a

| 53.74% | O: 8.94% H: 0.0% C: -7.65%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -7.24% | O: -0.36% H: 1.01% C: 0.82%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 15.14% | O: 0.29% H: 1.35% C: 0.87%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 20.56% | O: 0.64% H: 1.56% C: 0.9%
KMDA | News | $5.05 -0.98% -0.99% 27K |

Health Technology

| 7.26% | O: 2.31% H: 1.86% C: -0.2%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 18.15% | O: 0.09% H: 0.64% C: -0.45%
business update financial results

---

Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published: 2023-05-17 (Crawled : 01:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| -10.51% | O: -1.32% H: 0.92% C: -1.34%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -9.46% | O: -0.51% H: 0.0% C: -1.05%
FUSN | $21.26 0.05% 0.05% 440K |

Health Technology

| 365.79% | O: -1.54% H: 1.34% C: -2.67%
DFFN 4 | $6.6 11.68% -34.32% 350K |

Health Technology

| 14.59% | O: -0.25% H: 0.0% C: -0.78%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -9.32% | O: 0.07% H: 0.03% C: -0.84%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 16.26% | O: -0.82% H: 0.03% C: -0.44%
propel report expected treatment global growth glioblastoma market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---